tiprankstipranks
Trending News
More News >
Stille AB (SE:STIL)
:STIL
Sweden Market
Advertisement

Stille AB (STIL) Price & Analysis

Compare
0 Followers

STIL Stock Chart & Stats


STIL FAQ

What was Stille AB’s price range in the past 12 months?
Stille AB lowest stock price was kr179.50 and its highest was kr275.00 in the past 12 months.
    What is Stille AB’s market cap?
    Stille AB’s market cap is kr2.06B.
      When is Stille AB’s upcoming earnings report date?
      Stille AB’s upcoming earnings report date is Oct 23, 2025 which is in 71 days.
        How were Stille AB’s earnings last quarter?
        Stille AB released its earnings results on Jul 17, 2025. The company reported kr1.104 earnings per share for the quarter, missing the consensus estimate of kr2.047 by -kr0.943.
          Is Stille AB overvalued?
          According to Wall Street analysts Stille AB’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Stille AB pay dividends?
            Stille AB pays a Annually dividend of kr1.8 which represents an annual dividend yield of N/A. See more information on Stille AB dividends here
              What is Stille AB’s EPS estimate?
              Stille AB’s EPS estimate is 1.15.
                How many shares outstanding does Stille AB have?
                Stille AB has 8,985,447 shares outstanding.
                  What happened to Stille AB’s price movement after its last earnings report?
                  Stille AB reported an EPS of kr1.104 in its last earnings report, missing expectations of kr2.047. Following the earnings report the stock price went down -0.877%.
                    Which hedge fund is a major shareholder of Stille AB?
                    Currently, no hedge funds are holding shares in SE:STIL

                    Company Description

                    Stille AB

                    Stille AB (STIL) is a Swedish company specializing in the development and manufacturing of high-quality surgical instruments and equipment for the healthcare sector. Founded in 1841, Stille has a long history of innovation and expertise in surgical solutions. The company primarily operates in the medical technology sector, focusing on advanced surgical instruments for various specialties, including orthopedics, general surgery, and minimally invasive procedures. Stille's core products include surgical scissors, forceps, and specialized instruments designed to enhance the precision and efficiency of surgical procedures.

                    Stille AB (STIL) Earnings & Revenues

                    STIL Stock 12 Month Forecast

                    Average Price Target

                    kr259.00
                    ▲(15.63% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"185":"kr185","260":"kr260","203.75":"kr203.8","222.5":"kr222.5","241.25":"kr241.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":259,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">kr259.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":259,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">kr259.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":259,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">kr259.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[185,203.75,222.5,241.25,260],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,226,228.53846153846155,231.07692307692307,233.6153846153846,236.15384615384616,238.69230769230768,241.23076923076923,243.76923076923077,246.30769230769232,248.84615384615384,251.3846153846154,253.9230769230769,256.46153846153845,{"y":259,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,226,228.53846153846155,231.07692307692307,233.6153846153846,236.15384615384616,238.69230769230768,241.23076923076923,243.76923076923077,246.30769230769232,248.84615384615384,251.3846153846154,253.9230769230769,256.46153846153845,{"y":259,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,226,228.53846153846155,231.07692307692307,233.6153846153846,236.15384615384616,238.69230769230768,241.23076923076923,243.76923076923077,246.30769230769232,248.84615384615384,251.3846153846154,253.9230769230769,256.46153846153845,{"y":259,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":218,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":210,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":212,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":217,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":208,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":243,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":236,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":227,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":186,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":217,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":209,"date":1751328000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":226,"date":1754006400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":226,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    C-Rad AB Class B
                    Integrum AB Class B
                    Sedana Medical AB
                    Vicore Pharma Holding AB
                    Xspray Pharma AB
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis